Schlichting Jennifer A, Mengeling Michelle A, Makki Nader M, Malhotra Ashish, Halfdanarson Thorvardur R, Klutts J Stacey, Levy Barcey T, Kaboli Peter J, Charlton Mary E
From the VA Office of Rural Health, Rural Health Resource Center, Central Region, Iowa City, IA (JAS, MAM, AM, PJK, MEC); the Comprehensive Access and Delivery Research and Evaluation (CADRE) Center and Pathology and Laboratory Medicine (JSK), Iowa City VA Healthcare System, Iowa City, IA (JAS, MAM, AM, PJK, MEC); the Department of Epidemiology, University of Iowa College of Public Health, Iowa City (JAS, BTL, MEC); the Division of General Internal Medicine, Department of Internal Medicine (MAM, NMM, PJK), the Department of Pathology (JSK), and the Department of Family Medicine (BTL), University of Iowa Carver College of Medicine, Iowa City; and the Division of Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ (TRH).
J Am Board Fam Med. 2015 Jul-Aug;28(4):494-7. doi: 10.3122/jabfm.2015.04.140241.
The objective of this study was to determine what proportion of veterans previously screened for colorectal cancer (CRC) using fecal immunochemical testing (FIT) would be willing to undergo a second round of FIT screening.
Patients in the Iowa City Veterans Affairs Health Care System (<65 years old, asymptomatic, average risk, overdue for CRC screening) who completed a mailed FIT (April 2011 to May 2012) were contacted 1 year later by telephone to collect demographic and recent CRC screening information, and were offered a second mailed FIT if eligible.
Of 204 veterans who completed initial FIT testing, 159 were eligible to participate in a second round of FIT screening; 132 (83%) participated in the telephone survey, and 126 (79%) completed a second annual FIT, with 10 (8%) individuals testing positive. The majority of participants (67%) reported being more likely to take a yearly FIT than a colonoscopy every 10 years. Participants overwhelmingly reported that the FIT was easy to use and convenient (89%), and they were likely to complete a mailed FIT each year (97%).
Those willing to take a mailed FIT seem satisfied with this method and willing to do it annually. Population-based or provider-based FIT mailing programs have the potential to increase CRC screening in overdue populations.
本研究的目的是确定先前使用粪便免疫化学检测(FIT)进行过结肠直肠癌(CRC)筛查的退伍军人中,愿意接受第二轮FIT筛查的比例。
对爱荷华市退伍军人事务医疗保健系统中年龄小于65岁、无症状、平均风险且CRC筛查逾期的患者(2011年4月至2012年5月完成邮寄FIT检测),在1年后通过电话联系,收集人口统计学和近期CRC筛查信息,符合条件者可提供第二轮邮寄FIT检测。
在204名完成初始FIT检测的退伍军人中,159人有资格参加第二轮FIT筛查;132人(83%)参与了电话调查,126人(79%)完成了第二轮年度FIT检测,其中10人(8%)检测呈阳性。大多数参与者(67%)报告称,比起每10年做一次结肠镜检查,他们更愿意每年接受一次FIT检测。绝大多数参与者报告称FIT使用方便(89%),且他们很可能每年完成一次邮寄FIT检测(97%)。
愿意接受邮寄FIT检测的人似乎对这种方法感到满意,并愿意每年进行检测。基于人群或基于医疗服务提供者的FIT邮寄计划有潜力提高逾期人群的CRC筛查率。